Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasunobu Nagata

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Venetoclax resistance and molecular abnormalities in AML]Yasunobu Nagata
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Molecular international prognostic scoring system for myelodysplastic syndromes]Yasunobu Nagata
International Journal of Hematology|August 16, 2024
Molecular pathophysiology of germline mutations in acute myeloid leukemiaYasunobu Nagata
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2017
A novel prognostic model incorporating genetic profiling for myelodysplastic syndromesYasunobu Nagata, Seishi Ogawa
Leukemia|November 2, 2019
The functional mechanisms of mutations in myelodysplastic syndromeYasunobu Nagata, Jaroslaw P Maciejewski
International Journal of Hematology|April 21, 2010
Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusionYasunobu Nagata, Kazuteru Ohashi, Shiomi Fukuda, et al.
International Journal of Hematology|March 2, 2010
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phaseYasunobu Nagata, Shiomi Fukuda, Takeshi Kobayashi, et al.
Bioinformatics (Oxford, England)|September 7, 2014
Genomon ITDetector: a tool for somatic internal tandem duplication detection from cancer genome sequencing dataKenichi Chiba, Yuichi Shiraishi, Yasunobu Nagata, et al.
International Journal of Hematology|July 25, 2014
Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndromeKazuhiro Maki, Ko Sasaki, Yasunobu Nagata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]Yasunobu Nagata, Yasushi Omuro, Tatsu Shimoyama, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Venetoclax resistance and molecular abnormalities in AML]Yasunobu Nagata
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Molecular international prognostic scoring system for myelodysplastic syndromes]Yasunobu Nagata
International Journal of Hematology|August 16, 2024
Molecular pathophysiology of germline mutations in acute myeloid leukemiaYasunobu Nagata
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2017
A novel prognostic model incorporating genetic profiling for myelodysplastic syndromesYasunobu Nagata, Seishi Ogawa
Leukemia|November 2, 2019
The functional mechanisms of mutations in myelodysplastic syndromeYasunobu Nagata, Jaroslaw P Maciejewski
International Journal of Hematology|April 21, 2010
Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusionYasunobu Nagata, Kazuteru Ohashi, Shiomi Fukuda, et al.
International Journal of Hematology|March 2, 2010
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phaseYasunobu Nagata, Shiomi Fukuda, Takeshi Kobayashi, et al.
Bioinformatics (Oxford, England)|September 7, 2014
Genomon ITDetector: a tool for somatic internal tandem duplication detection from cancer genome sequencing dataKenichi Chiba, Yuichi Shiraishi, Yasunobu Nagata, et al.
International Journal of Hematology|July 25, 2014
Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndromeKazuhiro Maki, Ko Sasaki, Yasunobu Nagata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]Yasunobu Nagata, Yasushi Omuro, Tatsu Shimoyama, et al.
Pageof 7